...
首页> 外文期刊>Endocrine Connections >Radiological differentiation of phaeochromocytoma from other malignant adrenal masses: importance of wash-in characteristics on multiphase CECT
【24h】

Radiological differentiation of phaeochromocytoma from other malignant adrenal masses: importance of wash-in characteristics on multiphase CECT

机译:嗜铬细胞瘤与其他恶性肾上腺肿块的放射学鉴别:冲洗特性对多相CECT的重要性

获取原文
           

摘要

Rationale and introduction To evaluate the computerised tomography (CT) characteristics of phaeochromocytoma (PCC) that differentiate them from other non-benign adrenal masses such as adrenocortical carcinoma (ACC), primary adrenal lymphoma (PAL) and adrenal metastases (AM). Methods This retrospective study was conducted at a tertiary health care institute from Western India. Patients presented between January 2013 and August 2016 with histological diagnosis of PCC or other non-benign adrenal mass having adequate reviewable imaging data comprising all four CECT phases were included. Results The study cohort consisted of 72 adrenal masses from 66 patients (33 PCC, 22 ACC, 4 PAL, 13 AM). Unlike other masses, majority of PCC (25/33) showed peak enhancement in early arterial phase (EAP). PCC had significantly higher attenuation in EAP and early venous phase (EVP), and higher calculated percentage arterial enhancement (PAE) and percentage venous enhancement (PVE) than other adrenal masses ( P ?&?0.001). For diagnosis of PCC with 100% specificity, PAE value ≥100% and EAP attenuation ≥100?HU had 78.8 and 63.6% sensitivity respectively. ACC were significantly larger in size as compared to PCC and metastasis. The adreniform shape was exclusively found in PAL (two out of four) and AM (4 out of 13). None of the enhancement, wash-in or washout characteristics were discriminatory among ACC, PAL and AM. Conclusion Peak enhancement in EAP, PAE value ≥100% and EAP attenuation ≥100?HU differentiate PCC from other malignant adrenal masses with high specificity.
机译:原理和简介为了评估嗜铬细胞瘤(PCC)的计算机断层扫描(CT)特征,以将它们与其他非良性肾上腺肿块(如肾上腺皮质癌(ACC),原发性肾上腺淋巴瘤(PAL)和肾上腺转移瘤(AM))区分开来。方法这项回顾性研究是在印度西部的一家三级医疗机构进行的。纳入2013年1月至2016年8月之间具有PCC或其他非良性肾上腺肿块组织学诊断的患者,这些患者具有足够的可复查影像数据,包括所有四个CECT期。结果研究队列包括来自66位患者(33 PCC,22 ACC,4 PAL,13 AM)的72个肾上腺肿块。与其他肿块不同,大多数PCC(25/33)在早期动脉期(EAP)中显示出峰值增强。与其他肾上腺肿块相比,PCC在EAP和早期静脉阶段(EVP)中的衰减明显更高,并且计算出的动脉增强百分比(PAE)和静脉增强百分比(PVE)也更高(P≤0.001)。对于诊断PCC具有100%的特异性,PAE值≥100%和EAP衰减≥100?HU分别具有78.8和63.6%的敏感性。与PCC和转移相比,ACC的大小明显更大。肾上腺形状仅在PAL(四分之二)和AM(13分之四)中发现。在ACC,PAL和AM之间,没有增强,浸入或洗出特性的差异。结论EAP的峰值增强,PAE值≥100%和EAP衰减≥100?HU将PCC与其他恶性肾上腺肿块区分开来,具有很高的特异性。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号